Skip to main content
OpenTrials
Completed

NCT Number: NCT03468036

Intratracheal Suctioning and Oxygenation at Extubation

Data analysis of routinely applied extubation procedures on the ICU: i.e. extubation with 100% O2 vs. 35% O2 with/without suctioning.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Dept. of Intensive Care Medicine, University of Bern,

Bern, 3010, Switzerland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All adult (≥18 years) ICU patients with routine extubation on the ICU during the 2-month observational interval.

Exclusion criteria

  • Age < 18 years
  • Patients on comfort therapy and/ or terminal extubation or accidental extubationtracheostomized patients
  • Patients with refusal to general consent or withdrawal of general consent (DLF and/or internal database)
  • Patients dying without next-of-kin available

Treatment and study plan

none, does not apply

Other

none: does not apply

Primary outcomes

  1. Difference in proportion of patients with need for ongoing ventilatory support

    Time frame: 30 days max follow-up

Sponsors and collaborators

Lead sponsor

Jörg Schefold

Other

Registry information

Official study title

Intratracheal Suctioning and Oxygenation at Extubation (INnovATE)

Acronym: INNOVATE

Important dates

Study start
2019
Primary completion
2022
Study completion
2022
First posted
Mar 16, 2018
Registry last updated
Jan 26, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.